dr. petrylak on sequencing of targeted agents in bladder cancer
Published 7 years ago • 29 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:11
dr. petrylak on sequencing agents in prostate cancer
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
0:57
dr. black on sequencing of immunotherapy in bladder cancer
-
1:41
dr. petrylak on immunotherapy for second-line treatment in bladder cancer
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:08
dr. petrylak on the future immunotherapy in bladder cancer
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
0:47
dr. petrylak on the recent developments in prostate cancer
-
1:43
dr. petrylak discusses sequencing prostate cancer therapies
-
1:29
dr. daniel petrylak on the imvigor study of atezolizumab in advanced bladder cancer
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
1:43
dr. petrylak on imaging approaches in prostate cancer
-
1:53
dr daniel petrylak explains pd-1, pd-l1 expression in bladder cancer treatment
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
0:47
dr. daniel petrylak describes the clinical investigation of prostvac in prostate cancer